Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience.

The effect of additional treatments after surgery in patients with primary cardiac sarcoma (PCS) remains unknown. The present study aims to evaluate the benefit of chemotherapy in patients with non-metastatic cardiac sarcomas after optimal resection. Between October 1979 and December 1995, 15 patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Llombart-Cussac, A., Pivot, X., Contesso, G., Rhor-Alvarado, A., Delord, J. P., Spielmann, M., Türsz, T., Le Cesne, A.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group|1 1998
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063231/
https://ncbi.nlm.nih.gov/pubmed/9862574
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items